Medical Genetics in Ophthalmology: Through the Lens of Genetics-Informed Therapies OnDemand-Genetic Testing

Video Transcription

Video Summary

Christy Lee discusses advancements in genetic testing for eye disorders, emphasizing its importance in diagnosis, management, risk assessment, and guiding clinical trials. She highlights sponsored testing programs like My Retina Tracker and IDYourIRD, which offer free or low-cost gene panels for inherited retinal diseases (IRDs), aiding patient enrollment in research and providing genetic counseling. Other sponsored tests target specific conditions such as Bardet-Biedl syndrome, early-onset cataracts, and Usher syndrome. Clinical testing decisions are personalized based on diagnosis, insurance, gene coverage, and patient preference, with options ranging from targeted panels to exome and genome sequencing. Research initiatives like iGene and the Medical College of Wisconsin program advance genetic discovery through comprehensive sequencing and functional analyses. Recent findings identify novel small nuclear RNAs linked to dominant retinitis pigmentosa, potentially explaining undiagnosed cases. Overall, the expanding testing landscape offers patients hope for precise diagnosis and future therapies, despite complexities in interpretation and test selection.

Asset Subtitle

Kristy Lee, MS

Keywords

genetic testing

inherited retinal diseases

gene panels

clinical trials

retinitis pigmentosa